Spuneti-i medicului dumneavoastra daca inca prezentati scaune de consistenta grasoasa sau alte probleme ale stomacului sau intestinului (simptome gastro-intestinale), deoarece este posibil sa fie necesara ajustarea dozei dumneavoastra.

Zarnu obstrukcija ir zināma komplikācija pacientiem ar cistisko fibrozi. Tādēļ zarnu nosprostojumam līdzīgu simptomu gadījumā jāņem vērā zarnu sašaurinājuma iespējamība (skatīt 4.8. apakšpunktu). Pastāstiet ārstam vai farmaceitam par visām zālēm, kuras lietojat, pēdējā laikā esat lietojis vai varētu lietot. Kérjük, forduljon orvosához vagy gyógyszerészéhez, ha úgy találja, hogy a Mezym forte 10000hatása túl erős vagy túl gyenge. Atentie: Daca sunteti afectat(a) de oricare dintre urmatoarele reactii adverse, nu mai luati Mezym 25000 si mergeti la medic cât mai repede posibil.

Luati intotdeauna Mezym 25000 exact asa cum v-a spus medicul dumneavoastra. Trebuie sa discutati cu medicul dumneavoastra sau cu farmacistul daca nu sunteti sigur. The enzymes are present in the form of pH-sensitive enteric-coated minitablets, which are filled into hard gelatin capsules. The minitablets, which are released from the capsule into the stomach, are enteric coated to resist inactivation at low pH. Once released, the minitablets are distributed into the stomach and pass into the duodenum where the enteric coating begins to dissolve and the enzymes are released when the pH reaches 5.5. Duodenal availability studies in adults indicate that following oral administration of Mezym forte HL capsules, measurable levels of enzymes are present in the duodenum. Pancreatin is not absorbed from the gastro-intestinal tract in appreciable amounts. Ja Jums rodas jebkādas blakusparādības, konsultējieties ar ārstu vai farmaceitu. Tas attiecas arī uz iespējamām blakusparādībām, kas nav minētas šajā instrukcijā. Skatīt 4. punktu.

Dosage recommendations for pancreatic enzyme replacement therapy were published following the Cystic Fibrosis Foundation Consensus Conferences.1, 2, 3 Mezim-Forte should be administered in a manner consistent with the recommendations of the Cystic Fibrosis Foundation Consensus Conferences (also known as Conferences) provided in the following paragraphs, except for infants. Although the Conferences recommend doses of 2,000 to 4,000 lipase units in infants up to 12 months, Mezim-Forte is available in a 3,000 lipase unit capsule. Therefore, the recommended dose of Mezim-Forte in infants up to 12 months is 3,000 lipase units per 120 mL of formula or per breast-feeding. Patients may be dosed on a fat ingestion-based or actual body weight-based dosing scheme. Daca intrerupeti tratamentul cu Mezym 25000 inainte de data stabilita de catre medic, este de asteptat ca efectul terapeutic sa nu apara sau starea de „digestie proasta” sa reapara. Ca toate medicamentele, Mezym 25000 poate provoca reactii adverse, cu toate ca nu apar la toate persoanele.

Mezym 10 000 V skrandyje neirios tabletės N10

Ir svarīgi ziņot par iespējamām nevēlamām blakusparādībām pēc zāļu reģistrācijas. Tādējādi zāļu ieguvumu/riska attiecība tiek nepārtraukti uzraudzīta. Veselības aprūpes speciālisti tiek lūgti ziņot par jebkādām iespējamām nevēlamām blakusparādībām Zāļu valsts aģentūrai, Jersikas ielā 15, Rīgā, LV 1003. Laktóz-monohidrát, mikrokristályos cellulóz, vízmentes szilícium-dioxid, kroszpovidon, magnézium‑sztearát (növényi)